Simmons Law Firm Investigates FDA Concern about Popular Birth Control’s Increased Risk of Blood Clot

Simmons Law Firm Continues to Investigate Rising Safety Concerns Surrounding Yaz and Yasmin, as Provided by Recent FDA Update St.Louis, IL (PRWEB) September 30, 2011 The Simmons Law Firm is investigating reports of the increased risk of blood clots in women taking the popular birth control drugs Yaz, Yasmin and other contraceptives that contain the active ingredient drospirenone. As cited in a recent FDA update, the Food and Drug Administration remains concerned about the possibility of serious to fatal blood clots occurring in women taking contraceptives that contain the active ingredien
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations